Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Procter & Gamble Company (PG) Releases Q2 2026 Earnings: Modest Revenue Growth but EPS Miss

None

Procter & Gamble Company (PG, $PG) reported Q2 2026 results. Total revenue was $22.2 billion, up 1.49% year-over-year but below the consensus estimate of $22.95 billion.

Key income statement items:

  • Gross profit: $11.4 billion (down 0.79% year-over-year).
  • Operating profit: $5.4 billion (down 6.53% year-over-year).
  • Net income attributable to common shareholders: $4.3 billion (down 6.72% year-over-year).
  • Cost of sales: $10.8 billion (up 3.99% year-over-year).
  • Diluted earnings per share: $1.78 (down 5.32% year-over-year) versus an estimate of $1.92.
  • Cash flow and balance sheet highlights:

  • Cash from operating activities: $5.0 billion (up 3.05% year-over-year).
  • Purchases of property, plant and equipment (capex): $1.2 billion (up 26.16% year-over-year).
  • Cash and cash equivalents: $10.8 billion; total liabilities: $74.0 billion (up 3.9% year-over-year).
  • Overall, revenue showed modest growth while gross margin, operating profit and net income contracted year-over-year, and diluted EPS came in below the analyst estimate, reflecting margin pressure in the quarter.

    Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

    Procter & Gamble Company (The) Insider Trading Activity

    PG Insider Trades

    Procter & Gamble Company (The) insiders have traded $PG stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.

    Here’s a breakdown of recent trading of $PG stock by insiders over the last 6 months:

    • JON R MOELLER (Chairman, President and CEO) has made 0 purchases and 2 sales selling 51,803 shares for an estimated $8,088,342.
    • SHAILESH JEJURIKAR (Chief Operating Officer) has made 0 purchases and 2 sales selling 17,025 shares for an estimated $2,657,488.
    • ANDRE SCHULTEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 15,891 shares for an estimated $2,477,831.
    • R. ALEXANDRA KEITH (CEO - Beauty) has made 0 purchases and 4 sales selling 13,717 shares for an estimated $2,156,107.
    • GARY A COOMBE (CEO - Grooming) has made 0 purchases and 2 sales selling 13,729 shares for an estimated $2,150,411.
    • JENNIFER L. DAVIS (CEO - Health Care) has made 0 purchases and 2 sales selling 11,823 shares for an estimated $1,843,177.
    • MARC S. PRITCHARD (Chief Brand Officer) sold 9,849 shares for an estimated $1,548,989
    • SUNDAR G. RAMAN (CEO-Fabric & Home Care) sold 9,554 shares for an estimated $1,511,050
    • SUSAN STREET WHALEY (Chief Legal Officer & Secy) has made 0 purchases and 3 sales selling 9,575 shares for an estimated $1,493,316.
    • MA. FATIMA FRANCISCO (CEO - Baby, Fem & Family Care) sold 9,100 shares for an estimated $1,431,191
    • BALAJI PURUSHOTHAMAN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 1,096 shares for an estimated $169,901.
    • MATTHEW W. JANZARUK (SVP - Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,044 shares for an estimated $158,608.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    Procter & Gamble Company (The) Hedge Fund Activity

    We have seen 1,583 institutional investors add shares of Procter & Gamble Company (The) stock to their portfolio, and 2,006 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    Procter & Gamble Company (The) Congressional Stock Trading

    Members of Congress have traded $PG stock 19 times in the past 6 months. Of those trades, 9 have been purchases and 10 have been sales.

    Here’s a breakdown of recent trading of $PG stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    Procter & Gamble Company (The) Analyst Ratings

    Wall Street analysts have issued reports on $PG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Jefferies issued a "Buy" rating on 12/17/2025
    • Wells Fargo issued a "Overweight" rating on 09/25/2025

    To track analyst ratings and price targets for Procter & Gamble Company (The), check out Quiver Quantitative's $PG forecast page.

    Procter & Gamble Company (The) Price Targets

    Multiple analysts have issued price targets for $PG recently. We have seen 9 analysts offer price targets for $PG in the last 6 months, with a median target of $161.0.

    Here are some recent targets:

    • Peter Grom from UBS set a target price of $161.0 on 01/14/2026
    • Robert Moskow from TD Cowen set a target price of $150.0 on 01/08/2026
    • Chris Carey from Wells Fargo set a target price of $158.0 on 01/05/2026
    • Andrea Teixeira from JP Morgan set a target price of $157.0 on 12/18/2025
    • Kaumil Gajrawala from Jefferies set a target price of $179.0 on 12/17/2025
    • Olivia Tong from Raymond James set a target price of $175.0 on 10/20/2025
    • Olivia Tong from B of A Securities set a target price of $174.0 on 10/08/2025

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles